N-(4-(5-(Dimethylamino)-2,3,4,5-tetrahydro-1H-benzo[b]azepine-1-carbonyl)phenyl)-2-methylbenzamide N-(4-(5-(二甲氨基)-2,3,4,5-四氢-1H-苯并[b]氮杂环庚烷-1-羰基)苯基)-2-甲基苯甲酰胺
CAS 137975-06-5 MFCD00908918
化学结构图
SMILES: CN(C)C1CCCN(C2C=CC=CC=21)C(=O)C1C=CC(=CC=1)NC(=O)C1C=CC=CC=1C
化学属性
| Mol. Formula | C27H29N3O2 |
|---|---|
| Mol. Weight | 427.545 |
别名和识别编码
| Chemical Name | N-(4-(5-(Dimethylamino)-2,3,4,5-tetrahydro-1H-benzo[b]azepine-1-carbonyl)phenyl)-2-methylbenzamide |
|---|---|
| Chemical Name Translation | N-(4-(5-(二甲氨基)-2,3,4,5-四氢-1H-苯并[b]氮杂环庚烷-1-羰基)苯基)-2-甲基苯甲酰胺 |
信息真实价格透明
资金保障
专业采购外包团队在线服务
信息真实价格透明
资金保障
专业采购外包团队在线服务
品牌质保精细包装
现货库存
一流品牌服务
相关文献及参考
- [2]. Yamaguchi K, et al. Clinical implication of the antidiuretic hormone (ADH) receptor antagonist mozavaptan hydrochloride in patients with ectopic ADH syndrome. Jpn J Clin Oncol. 2011 Jan;41(1):148-52.
- [1]. Yamamura Y, et al. Characterization of a novel aquaretic agent, OPC-31260, as an orally effective, nonpeptide vasopressin V2 receptor antagonist. Br J Pharmacol. 1992 Apr;105(4):787-91.
- [1]. Yamamura Y, et al. Characterization of a novel aquaretic agent, OPC-31260, as an orally effective, nonpeptide vasopressin V2 receptor antagonist. Br J Pharmacol. 1992 Apr;105(4):787-91.
- [2]. Yamaguchi K, et al. Clinical implication of the antidiuretic hormone (ADH) receptor antagonist mozavaptan hydrochloride in patients with ectopic ADH syndrome. Jpn J Clin Oncol. 2011 Jan;41(1):148-52.
